Format

Send to

Choose Destination
Can J Physiol Pharmacol. 2018 Nov 13:1-8. doi: 10.1139/cjpp-2018-0553. [Epub ahead of print]

High throughput screening reveals no significant changes in protein synthesis, processing, and degradation machinery during passaging of mesenchymal stem cells 1.

Author information

1
a Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
2
b Regenerative Medicine Program, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
3
c School of Biomedical and Healthcare Sciences, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, England.

Abstract

Increasing reports of successful and safe application of bone marrow derived mesenchymal stem cells (BM-MSCs) for cell therapy are pouring in from numerous studies. However poor survival of transplanted cells in the recipient has impaired the benefits of BM-MSCs based therapies. Therefore cell product preparation procedures pertaining to MSC therapy need to be optimized to improve the survival of transplanted cells. One of the important ex vivo procedures in the preparation of cells for therapy is passaging of BM-MSCs to ensure a suitable number of cells for transplantation, which may affect the turnover of proteins involved in regulation of cell survival and (or) death pathways. In the current study, we investigated the effect of an increase in passage number of BM-MSCs in cell culture on the intracellular protein turnover (protein synthesis, processing, and degradation machinery). We performed proteomic analysis of BM-MSCs at different passages. There was no significant difference observed in the ribosomal, protein processing, and proteasomal pathways related proteins in BM-MSCs with an increase in passage number from P3 to P7. Therefore, expansion of MSCs in the cell culture in clinically relevant passages (Passage 3-7) does not affect the quality of MSCs in terms of intracellular protein synthesis and turnover.

KEYWORDS:

analyse protéomique; cellules souches mésenchymateuses; greffe; mesenchymal stem cells; proteomic analysis; regenerative therapy; thérapie régénératrice; transplantation

PMID:
30422687
DOI:
10.1139/cjpp-2018-0553

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center